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Our aim was to study the possible alterations of redox
status (enzymatic and nonenzymatic parameters and metal
elements) in erythrocytes of patients with hepatocellular
carcinoma (HCC), colorectal liver metastases (CRLM) and
benign liver neoplasms. The function of redox homeostasis
is closely connected to the energy level of erythrocytes,
therefore, the ATP level was also determined. Antioxidant
parameters, enzyme activities of superoxide dismutase
and glutathione peroxidase were estimated in the
erythrocytes of 11 patients with benign tumour, 23 patients
with primary malignant and 37 metastatic liver tumour
patients and 30 age-matched and sex-matched healthy
controls. Element content with inductively coupled plasma
optical emission spectrometer and ATP level by the
chemiluminometric method were also determined from the
samples. Free radical intensity was significantly increased,
whereas erythrocyte glutathione peroxidase and
superoxide dismutase activities were significantly
decreased in the HCC and CRLM groups versus benign
groups and controls. Se, Mn and Zn levels were lowered in
HCC and CRLM groups versus benign and control groups.
The content of Cu, Mg, Se and Zn changed significantly
between HCC and CRLM groups. Similarly, ATP
concentration decreased in HCC and CRLM versus controls
and benign groups. The lowest levels of ATP and
antioxidant enzyme activities were found in the case of
CRLM patients. These results reveal an alteration in the ATP
level of erythrocytes with concomitant changes in the
antioxidant defence system in hepatic cancer patients.
Altered redox homeostasis (oxidative damage) may lead to
decreased ATP level and consequently may play an
important role in primary carcinogenesis and generation
of metastases, as well. Eur J Gastroenterol Hepatol
20:393–398 c 2008 Wolters Kluwer Health | Lippincott
Williams & Wilkins.
European Journal of Gastroenterology & Hepatology 2008, 20:393–398
Keywords: ATP, liver neoplasms, metal elements, redox homeostasis
II Departments of aMedicine, bSurgery, cI Department of Surgery, dDepartment
of Transplantation and Surgery, Semmelweis University, eNational Research
Institute for Radiobiology and Radiohygiene, fChemical Research Center,
Hungarian Academy of Sciences and gDiachem Ltd, Budapest, Hungary
Correspondence to Dr Anna Blázovics, II Department of Medicine, Biochemical
Research Group, Semmelweis University, H-1088 Budapest, Szentkirályi u. 46,
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Introduction
Hepatic cancer continues to be one of the most
frequently diagnosed neoplasms and one of the leading
causes of mortality related to cancer. In the pathogenesis
of neoplastic and age-related degenerative diseases
oxidative stress seems to play a key role [1]. A wide
variety of reactive oxygen species (ROS) can cause
membrane destruction, protein aggregation and DNA
break. Endogenous defences against free radicals include
antioxidant enzymes such as the thoroughly studied
glutathione peroxidase (GSHPx) and superoxide dismu-
tase (SOD). Lower levels of essential antioxidants in
circulation were found to be associated with an increased
risk of cancer [2–4].
The processes of metastatization are decreased by free
radical formation [5]. Tumour cell interactions with
microvasculature is a rate-limiting step in metastasis
development. Initial interactions trigger a sequence of
activation pathways that involve cytokines, growth factors,
bioactive lipids and ROS produced by the cancer cell or the
endothelium. On the other hand, induction of endothelial
free radicals can be cytotoxic to cancer cells [6].
The presence of activated oncogenes and/or inactivated
tumour suppressor genes may result in constitutive
activation of multiple transcription factors. This may be
especially true in the early stages of tumour develop-
ment. At advanced stages, however, uncontrolled tumour
growth and the consequent development of a stress
microenvironment, such as free radical overproduction,
may further alter the activity of these transcription
factors. Abnormal activation of and interplay between
these factors lead to aberrant expression of multiple
metastasis-related proteins and confer a tremendous
survival and growth advantage to emerging metastatic
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variants [7]. Cytokines of serum, such as IL-6 and TNF-a,
proved to be related to oxidative stress in cancer patients
[8]. Exposure to chronic stress increased lipid peroxidation
level and free radical content of erythrocytes [9].
Therefore, we conducted investigations to evaluate the
possible alteration of oxidant/antioxidant and metal
element status in the circulation of patients with
hepatocellular carcinoma (HCC) and colorectal liver
metastases (CRLM) compared with patients with benign
neoplasms and healthy volunteers. Metal elements (Cu,
Mn, Se, Zn) play a key role in the function of antioxidant
enzyme activity of SOD and GSHPx. Determination of
these elements may explain biochemical changes owing
to the presence of oxidative stress related to tumour.
ATP concentration of erythrocytes was also determined.
A correlation between ATP level, element concentration
and redox homeostasis may provide relevant information
on supportive or therapeutic perspectives. Our aim was to
determine the difference between the prooxidant/anti-
oxidant balance (antioxidant parameters, metal elements)
of benign tumour and cancer, and to determine whether
there is a relationship between redox homeostasis and
ATP level.
On the basis of our earlier studies [10], erythrocytes may
be considered as markers of oxidative stress caused by
tumourous tissues. In addition, genetic and environmen-
tal factors (which are hard to interpret in certain cases) in
the background of the development of cancer are present.
We presume that the measurement of redox homeostasis
and energy level of the body offers new perspectives for




Eleven patients with diagnosis of benign liver neoplasm
(two hemangiomas, five, focal nodular hyperplasias, four
hepatocellular adenomas) (average age: 48.73 ± 10.26
years; between 32 and 62 years), 23 patients with HCC
diagnosis (average age: 50.17 ± 8.04 years; between 37
and 70 years) and 37 patients with CRLM diagnosis of
the liver (average age: 53.08 ± 8.72 years; between 39 and
72 years) who had not undergone previous treatment for
their liver tumour were examined in this study. Patients
were recruited from the I. Department of Surgery and
from the Department of Transplantation and Surgery,
Semmelweis University, Budapest, Hungary. Thirty
volunteers matching the age and sex of patients (average
age: 54.42 ± 8.15 years; between 36 and 62 years) were
selected as controls. Specific exclusion criteria for this
study were the following: hepatitis virus infection,
diabetes mellitus, heart or renal failure and oral
antioxidant supplementation. Some of the patients were
heavy drinkers, but none of them had consumed alcohol
48 h before blood collection. Informed consent was
obtained from all participants in the study before blood
collection.
The diagnosis of hepatic neoplasms was based on
computer tomography and ultrasonographic-fine needle
aspiration biopsy, and this diagnosis was verified by
histopathological examination of their postoperative
specimens. The study was approved by the TUKEB
Committee of Semmelweis University, Budapest, Hungary
(TUKEB No: 15/2004).
Laboratory methods
After an overnight fast, blood samples were drawn from
the antecubital vein by venipuncture into tubes contain-
ing sodium citrate. Plasma and erythrocyte samples were
separated and stored at – 201C until assayed.
Free SH-group concentrations of plasma samples were
determined by the Sedlak method on the basis of the
Ellmann reaction [11].
The H-donating ability of plasma samples was deter-
mined spectrophotometrically at 517 nm in the presence
of a 1,1-diphenyl-2-picryl-hydrasyl (DPPH) radical by
Blois’s method modified by Blázovics et al. [10]. For the
characterization of the ability, inhibition was expressed as
a percentage of DPPH degradation [12,13].
Oyaizu’s method was adapted for the determination of
the reducing power of plasma samples. The change in
absorbance was measured, which accompanied Fe3 + -Fe2 +
transformation at 700 nm [14]. All spectrophotometric
measurements were carried out with a Jasco V-550
instrument (Jasco Europe, Cremella, Italy).
A chemiluminescent assay adapted to a Berthold Lumat
9501 instrument was applied (Berthold Technologies,
Bad Wildbad, Germany). The procedure was carried out
by the method of Blázovics et al. [10]. The volume of each
plasma and red blood cell (RBC) sample was 0.100 ml.
Chemiluminescent intensity of the samples was expressed
in relative light units (basic chemical reaction means:
H2O2-microperoxidase-luminol reaction).
The level of total antioxidant status from the plasma, and
the activity of GSHPx and SOD were determined from
the RBC samples with Randox kits. The results were
expressed in arbitrary units calculated from the absor-
bance detected by spectrophotometry.
Element concentration of erythrocyte lysates was deter-
mined in three parallel measurements with an inductively
coupled plasma optical emission spectrometer. The type
of instrument used was Atom Scan 25 (Thermo Jarrell
Ash Co. Franklin, Massachusetts, USA). After digestion
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of the RBC samples with a mixture of nitric acid and
hydrogen peroxide and dilution with deionized water, the
concentration of Ca, Cu, Fe, Mg, Mn, P, S and Zn
elements was determined. Three times 3-s integration
time, blank subtraction and background correction were
applied during the measurements [15].
Se content of erythrocytes was determined with a hanging
mercury drop electrode by a cathodic stripping voltametric
method (instrument: Trace Lab 50). For element measure-
ment, the digested samples were measured in 1 mol/l HCl
as supporting electrolyte by preconcentration at – 350 mV.
Electrolysis time was 100 s, potential: from – 300 mV up
to – 900 mV, step duration – 50 mV/s.
ATP concentration of erythrocytes was determined by a
chemiluminescent technique adapted to a Leader 50
luminometer (Gen-Probe Inc., San Diego, California, USA)
based on the luciferin–luciferase method. The method
described by Rieger [16] was modified. Hemolyzed RBC
samples (stored on – 201C) with hemoglobin content set
to 1 g% were diluted (100 ) with bidistilled water and
centrifuged (with 2500g for 10 min at 01C). These
supernatants were 0.01 g%. Standard luciferin–luciferase
solution: lyophilized luciferin–luciferase was diluted with
bidistilled water to 1 mg/ml concentration. ATP was
diluted to 10 – 6 mol/l with bidistilled water to gain a
standard solution. Both of these solutions were freshly
prepared on the day of the measurement. About 25ml of
erythrocyte supernatants were added to the luciferin–
luciferase solution. The number of intervals was five,
interval time was 10 s, detection time was 50 s. The results
were expressed as a percentage of the control values.
Materials
Luminol, microperoxidase, hydrogen peroxide, DPPH
radical, luciferin–luciferase (Cat. No. L 0633) and ATP
standard (Cat. No. 8937) were obtained from SIGMA
(St Louis, Missouri, USA). Total antioxidant status
(NX2332), SOD (SD 125) and GSHPx (RS 506) kits
were bought from Randox (Crumlin, UK), the standard
solution for ICP measurements was made from Spectars-
can (Kolbotn, Norway) and High Purity Standards
(Charleston, South Carolina, USA), and other chemical
reagents were purchased from Reanal Ltd (Budapest,
Hungary).
Statistical analysis
Comparison among the different groups was carried out
by analysis of variance tests. The difference between two
groups was examined by the Student’s t-probe. The
figures show mean ± SD. Significance levels were deter-
mined at P < 0.05.
Results
In this study characteristic changes in the redox
parameters of blood in cancer patients have been
determined. Chemiluminescent activity of the plasma
was significantly higher in HCC and CRLM patients
versus controls (P < 0.05) and versus patients with
benign liver neoplasm (P < 0.05). No significant differ-
ence was measured between the plasma relative light unit
values of the two cancer groups. Other plasma redox
parameters (H-donating ability, reducing power, SH-
group concentration) were significantly lower in HCC
and CRLM patients versus controls (P < 0.05) and versus
patients with benign liver neoplasm (P < 0.05). No
significant difference was found between these values
of the two cancer groups (Table 1).
Our measurements showed significant increase in free
radical content with concomitant significant decrease in
GSHPx and CuZn-SOD activities in the erythrocytes of
HCC and CRLM patients versus controls (P < 0.05) and
versus patients with benign liver neoplasm (P < 0.05)
(Figs 1–3). These values were significantly different
between HCC and CRLM groups, indicating that
processes of metastatization were connected with greater
imbalance of redox homeostasis. Cu, Se and Zn (elements
crucial for antioxidant enzyme activity) levels were
significantly lower in the erythrocytes of cancer patients
versus controls (P < 0.05) and also in the benign group
(P < 0.05). Alterations in the content of other macro
elements (Ca, Mg) may imply that the whole element
homeostasis is affected by the oxidative stress of
tumourous processes (Table 2).
ATP concentration in the erythrocytes of HCC and
CRLM groups decreased significantly compared with the
control and benign groups (P < 0.05). In addition, ATP
content decreased significantly in the CRLM group
versus the HCC group (P < 0.05) (Fig. 4).
Table 1 Redox parameters in the plasma of patients with different liver tumors
Controls Benign HCC CRLM
Chemiluminescent intensity of plasma (RLU) 1.99106 ± 9.6105 2.15106 ± 2.0105 1.16107 ± 7.86106a 1.42107 ± 9.75106a
H-donor ability of plasma (Inhibition %) 65.87 ± 7.11 60.05 ± 9.30 44.35 ± 5.44a 40.55 ± 6.26a
Reducing power of plasma (mmol AS/ml) 1.721 ± 0.193 1.604 ± 0.286 1.058 ± 0.168a 0.927 ± 0.126a
SH-group concentration of plasma (mmol/l) 0.523 ± 0.039 0.509 ± 0.045 0.350 ± 0.046a 0.316 ± 0.050a
TAS level of plasma (arbitrary unit) 1.107 ± 0.115 1.164 ± 0.121 0.965 ± 0.072a 0.872 ± 0.109a
CRLM, colorectal liver metastases; HCC, hepatocellular carcinoma; RLU, relative light unit; TAS, total antioxidant status.
aSignificant versus control and benign groups, P < 0.05.
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On the basis of these findings, redox parameters of
erythrocytes seem to be more suitable than parameters
of plasma for monitoring the redox status of tumour
patients.
Discussion
The relationship between changes in the redox home-
ostasis of the body and the development of cancer is not
yet completely clear. It is generally believed that
generation of free radicals and accelerated lipid peroxida-
tion are etiologic factors in cancer development. It is still
not clarified, however, whether accelerated ROS forma-
tion leads to neoplastic malformation, or pathways of
dysplasia induce free radical production, or whether these
pathways are part of a circulus vitiosus. The ATP content
of the tissues has a close connection with the essential
biochemical pathways and plays a key role in the
regulation of redox homeostasis [17]; and similarly, ATP
content is affected by oxidative stress [18]. Erythrocytes
are even susceptible to ‘apoptosis’ following phosphate
and ATP depletion [19]. As red blood cells have a close
physical connection with the tissues of the whole body,
measuring their redox status and ATP concentration may
provide relevant information on changes owing to the
neoplastic reactions of the liver as well.
We have found elevated free radical content and
increased levels of oxidative stress of plasma and
erythrocyte samples in HCC and CRLM groups versus
controls and benign groups. The worst antioxidant level
was found in the CRLM group. This indicates that the
progress of neoplastic process may be a key factor of
oxidative damage. Lipid peroxidation and oxidative stress
are thought to be more prominent in erythrocytes than in
the plasma of cancer patients. The erythrocytes are
particularly vulnerable to oxidative damage because of
exposure to high oxygen tension, high content of
polyunsaturated fatty acids and the presence of large
amounts of iron [4,20]. In our study, the levels of SOD
and GSHPx enzymes along with the content of Cu, Se
and Zn elements in the erythrocytes of the HCC and
CRLM groups were significantly lower than in the benign
group and in healthy controls. As described in the
literature, Cu and Zn are essential for the function of
SOD enzyme, whereas Se is essential for GSHPx [21,22].
The content of certain elements in erythrocytes changed
parallel with the decrease in antioxidant parameters. It
has not been clarified, however, or whether these changes
are to be considered as primary or secondary, or they
cause a circulus vitiosus. Damage of the erythrocyte
membranes caused by free radicals may be an explanation
for the loss of certain elements and a compensatory
increase in the content of others, but there are other
potential mechanisms also. In the future, dietary













Chemiluminescent intensity of erythrocytes of patients with different
liver tumours (a, significant vs. control and benign groups; P < 0.05).
CRLM, colorectal liver metastases; HCC, hepatocellular carcinoma;














Control Benign HCC CRLM
Glutathione peroxidase activity of erythrocytes of patients with different
liver tumours (a, significant vs. control and benign groups; b, significant
vs. control, benign and HCC groups; P < 0.05). CRLM, colorectal liver
















Superoxide dismutase activity of erythrocytes of patients with different
liver tumours (a, significant vs. control and benign groups; b, significant
vs. control, benign and HCC groups; P < 0.05). CRLM, colorectal liver
metastases; HCC, hepatocellular carcinoma.
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role in the therapy of diseases related to oxidative stress
[21,23,24].
A few hypotheses might be offered to explain the depletion
of the antioxidant defence of the plasma: we assume that
circulating antioxidant enzymes might be used in an
attempt to counteract enhanced free radical generation in
the tumour-affected tissue. Another assumption is that the
high free radical content is owing to prolonged insufficient
power of a depleted antioxidant defence system. Further-
more, as GSHPx and SOD are themselves susceptible to
oxidation by the oxidative reactive molecules and lipid
peroxides, they could be inactivated by their own substrates
[25]. Deprivation of trace elements such as Cu, Zn and Se
could lead to the inactivation of antioxidant enzymes.
With the lower GSHPx and SOD activity in the cancer
groups, ROS (e.g. superoxide anion) were not eliminated
completely. Accumulation of these molecules may result
in binding and oxidization of DNA, lipids and proteins in
numerous organs.
Tumourous tissues with increased ROS generation cause
a low energy level of the body. Red cell proteome analysis
demonstrates that several proteins involved in ATP
synthesis, folding/chaperone function, redox regulation
and red cell metabolism show altered expression because
of oxidative damage to proteins [26]. Decreased ATP
content may cause deficiencies of membrane pump
function and osmolality of RBCs. Therefore, a marked
primary change in the content of major elements may
occur (e.g. Ca and Mg), which is connected to secondary
altered minor element content [27–29], and is deter-
mined by this study. Without mitochondria RBCs are,
however, sensitive to ATP loss, and energy depletion
causes cell shrinkage and ‘programmed cell death’
through Ca2 + influx and PKC activation [30].
The results reveal an alteration in the antioxidant
defence system (in plasma and erythrocytes) with
concomitant changes in the element content of RBCs
in cancer patients. Whether the alterations in the
antioxidant status are the cause or consequence of the
enhanced ROS generation remains unclear. We presume
that an altered prooxidant–antioxidant balance may lead
to oxidative damage and play an important role in hepatic
carcinogenesis. It seems that oxidative damage is closely
connected to alterations of metal element content in
erythrocytes. Depletion of elements, which are essential
for antioxidant enzyme activities, such as Cu, Se and Zn,
leads to a circulus vitiosus. Sulphur content is strongly
connected to the activity of enzymes with SH groups.
Imbalance of the redox state and element homeostasis
may cause insufficient ATP generation and/or transfer.
Further research should be carried out to find out
whether oxidative stress-related parameters could be
used as differential diagnostic and prognostic tools in the
therapy of benign and malignant liver neoplasms. The
presence of the impaired antioxidant status may be a risk
factor of both primary and metastatic tumourigenesis of
the liver.
On the basis of our findings, redox parameters of
erythrocytes seem to be sensitive factors for monitoring
the clinical status of tumour patients.
Table 2 Alterations in the element content of erythrocytes in patients with different liver tumors
Controls Benign HCC CRLM
Ca (mg/g) 6.13 ± 2.55 5.51 ± 2.99 7.23 ± 1.98 8.47 ± 2.154
Cu (mg/g) 0.387 ± 0.033 0.376 ± 0.046 0.279 ± 0.061a 0.209 ± 0.077a
Fe (mg/g) 449.1 ± 47.3 464.8 ± 61.6 527.1 ± 87.5 397.2 ± 156.4
Mg (mg/g) 14.30 ± 3.46 13.54 ± 2.56 21.78 ± 5.89a 20.87 ± 4.90a
Mn (mg/g) 0.0725 ± 0.0137 0.0643 ± 0.0074 0.0181 ± 0.0123a 0.0271 ± 0.0159a
P (mg/g) 301.8 ± 39.3 295.4 ± 51.2 357.7 ± 95.0 320.7 ± 83.7
S (mg/g) 1257 ± 64 1297 ± 82 1066 ± 132a 912 ± 159a
Se (mg/kg) 301.3 ± 57.2 313.7 ± 83.7 128.8 ± 58.3a 61.5 ± 39.9b
Zn (mg/g) 6.11 ± 1.10 5.20 ± 1.51 2.82 ± 0.89a 1.95 ± 1.12a
CRLM, colorectal liver metastases; HCC, hepatocellular carcinoma.
aSignificant versus control and benign groups.











ATP content of erythrocytes of patients with different liver tumours
(a, significant vs. control and benign groups; b, significant vs. control,
benign and HCC groups; P < 0.05). CRLM, colorectal liver metastases;
HCC, hepatocellular carcinoma.
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